Trial Profile
Comparison of Glycemic Response to Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes Using Continuous Glucose Monitoring.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2017
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 07 Apr 2009 New trial record